DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
Teradata Corp
TDC
Halozyme Therapeutics
HALO
Collegium Pharmaceutical
COLL
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -118.61%-1.16M | 11.54%-1.04M | 2.70%-4.43M | 71.86%-7.74M | 33.36%-1.47M | 45.60%-532K | 91.67%-1.18M | 55.20%-4.55M | -315.59%-27.49M | -16.94%-2.21M |
Net income from continuing operations | -934.95%-20.7M | 354.93%4.16M | -141.97%-21.2M | -86.00%-25.44M | -877.30%-13.05M | 35.32%-2M | -115.91%-1.63M | 55.10%-8.76M | -0.50%-13.68M | 74.56%-1.34M |
Operating gains losses | --15.94M | -219.40%-8.35M | 284.51%16.19M | 270.09%8.64M | ---- | ---- | 83.02%-2.61M | -69.79%4.21M | -2,132.80%-5.08M | ---2.18M |
Depreciation and amortization | -3.58%646K | 21.13%642K | 39.78%629K | 227.77%2.28M | 153.23%628K | 352.70%670K | 244.16%530K | 210.34%450K | -31.12%695K | 72.22%248K |
Other non cash items | 197.44%1.28M | 269.21%1.16M | 72.28%777K | 124.43%1.86M | 34.08%661K | -14.20%429K | 103.45%315K | -18.15%451K | -399.92%-7.6M | -15.87%493K |
Change In working capital | -45.12%765K | -84.18%260K | -34.47%-1.86M | 181.03%2.67M | 488.95%1.01M | -42.47%1.39M | 416.57%1.64M | 74.28%-1.38M | -210.31%-3.29M | -93.24%172K |
-Change in prepaid assets | ---- | 117.73%184K | 0.28%-703K | 77.79%-440K | ---- | ---- | -160.80%-1.04M | 79.86%-705K | -526.90%-1.98M | -153.25%-213K |
-Change in payables and accrued expense | 97.65%-24K | -97.17%76K | -70.71%-1.15M | 336.79%3.11M | 452.47%2.13M | -449.15%-1.02M | 2,315.70%2.68M | 63.85%-676K | -139.76%-1.31M | -82.03%385K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -118.61%-1.16M | 11.54%-1.04M | 2.70%-4.43M | 71.86%-7.74M | 33.36%-1.47M | 45.60%-532K | 91.67%-1.18M | 55.20%-4.55M | -315.59%-27.49M | -16.94%-2.21M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -348.64%-46.17M | 139.17%20.66M | -6.72%33.87M | 91.34%-16.27M | -171.58%-18.41M | 176.61%18.57M | -411.18%-52.74M | 120.29%36.31M | -1,074.43%-187.84M | 348.06%25.71M |
Net PPE purchase and sale | -131.11%-36.76M | 40.97%-9.22M | -2.97%-9.39M | -22.13%-56.14M | -59.38%-15.5M | -5.89%-15.9M | -77.64%-15.61M | 26.63%-9.12M | -187.40%-45.97M | 6.17%-9.73M |
Net business purchase and sale | --0 | ---- | ---- | --1.79M | --0 | --0 | ---- | ---- | --0 | --0 |
Net investment purchase and sale | -127.30%-9.41M | 178.20%29.88M | -7.46%43.27M | 128.72%40.12M | -108.14%-2.91M | 574.67%34.48M | -2,398.89%-38.21M | 128.07%46.76M | ---139.67M | --35.68M |
Net other investing changes | ---- | ---- | ---- | 7.23%-2.04M | --0 | ---3K | ---716K | ---1.32M | ---2.2M | ---244K |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -348.64%-46.17M | 139.17%20.66M | -6.72%33.87M | 91.34%-16.27M | -171.58%-18.41M | 176.61%18.57M | -411.18%-52.74M | 120.29%36.31M | -1,074.43%-187.84M | 348.06%25.71M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -73.33%-806K | 1,602.22%676K | 299K | 3.95%54.87M | 55.38M | -150.49%-465K | -45K | 0 | -76.69%52.79M | 0 |
Net issuance payments of debt | 5.16%-441K | -850.00%-456K | ---446K | ---1.76M | ---1.25M | ---465K | ---48K | --0 | --0 | --0 |
Net common stock issuance | --0 | ---- | ---- | 27.36%57.31M | --57.31M | --0 | ---- | ---- | --45M | --0 |
Proceeds from stock option exercised by employees | --0 | 49,433.33%1.49M | --1.47M | 16,566.67%500K | --497K | --0 | --3K | --0 | --3K | --0 |
Net other financing activities | ---365K | ---444K | ---729K | -115.11%-1.18M | ---- | ---- | ---- | ---- | 201.06%7.79M | --0 |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -73.33%-806K | 1,602.22%676K | --299K | 3.95%54.87M | --55.38M | -150.49%-465K | ---45K | --0 | -76.69%52.79M | --0 |
Net cash flow | ||||||||||
Beginning cash position | 537.37%122.3M | 39.44%102.01M | 74.57%72.27M | -79.70%41.4M | 105.43%36.76M | -54.52%19.19M | 9.77%73.16M | -79.70%41.4M | 283,143.06%203.94M | -91.76%17.89M |
Current changes in cash | -373.96%-48.14M | 137.61%20.3M | -6.35%29.74M | 118.99%30.87M | 51.08%35.51M | 172.33%17.57M | -120.65%-53.97M | 123.13%31.76M | -179.73%-162.54M | 279.34%23.5M |
End cash Position | 101.76%74.17M | 537.37%122.3M | 39.44%102.01M | 74.57%72.27M | 74.57%72.27M | 105.43%36.76M | -54.52%19.19M | 9.77%73.16M | -79.70%41.4M | -79.70%41.4M |
Free cash flow | -130.77%-37.93M | 38.90%-10.26M | -1.08%-13.82M | 13.05%-63.88M | -42.22%-16.97M | -2.74%-16.44M | 26.77%-16.79M | 39.48%-13.68M | -224.91%-73.46M | 2.61%-11.93M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |